Medicareplus International was incorporated in 2007 with the aim of manufacturing innovative economic, patient centric solutions for chronic conditions that improve quality of life whilst helping clinicians around the world improve clinical outcomes.
Effectiveness through Research. Integrity through Innovation. One day, all patients around the world will have the opportunity to access cost effective, evidenced-based solutions that maintain skin integrity and advance wound healing.
Our mission is to work closely with our customers to create innovative, economic, patient centric, evidence based solutions that help clinicians around the world improve clinical outcomes.
Medicareplus International strives to be responsible corporate citizens by acting in an ethical and socially responsible manner, being an honest and trustworthy business partner and by providing evidence-based products supported by leading education platforms.
Medicareplus International (Medicareplus) was incorporated in 2007 with the aim of manufacturing a range of wound care products and medical devices strictly conforming to the required technical specifications for each product, for the UK, European and Global market.
In April 2008 the Company became part of the Chemilines Group of companies who have been established for over 25 years within the healthcare sector. Chemilines are recognised as one of the UK’s leading pharmaceutical importers and distributors of sourced branded medicines, generics and perfumes in the UK.
Over the last 9 years, Medicareplus has expanded and evolved to further improve patients’ lives.
Medicareplus International are a fast growing market innovator in the research, manufacture and distribution of cost effective, clinically proven protective and regenerative healthcare products that maintains skin integrity.
Our portfolio has rapidly grown to provide clinicians with a range of clinical and economical solutions that protects at risk or compromised skin, prevents infection, advances healing and restores quality of life for patients suffering from acute or complex chronic wounds, such as pressure ulcers, diabetic foot ulcers, venous leg ulcers and burns.
Our Product Portfolio
Specialists in skin integrity
Our flagship skin protectant range, MEDI DERMA-S® Barrier Cream and Film, is being widely adopted across the UK in both community and acute sectors as a gold standard in maintaining skin integrity whilst providing significant cost savings against leading brands*.
With new innovative skin care products already in the pipeline Medicareplus International are committed to leading the way in skin integrity through Total Barrier Protection™
In addition, we passionately believe in working collaboratively with our customers to develop, deliver and support bespoke professional educational programmes in accordance with your Trust’s requirements. Our highly qualified team will ensure the safe and effective use of our products whilst educating health care professional’s on underlying clinical conditions for which the products may be used.
All medical device products within the range are in compliance with the Medical Device Directive 93/42/EEC including revision 2007/47/EEC and CE marked.
Medicareplus International is accredited and certified in accordance with ISO 13485:2012 and to the Labour Standards Assurance System (LSAS) Policy.
You can view copies of our accreditation certificates and policies here: